This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Mimoun Ayoub, PhD
Senior VP, Global Head of Peptide and Oligonucleotide Platforms at CordenPharma International
Speaker

Profile

Dr. Mimoun Ayoub is a recognized leader in the peptide industry, dedicated to advancing peptide and oligonucleotide therapeutics. As Senior Vice President at CordenPharma, he has led global sales and now heads the Peptide and Oligonucleotide Platforms, driving innovation in synthesis and manufacturing. With a Ph.D. from Pierre and Marie Curie University, Dr. Ayoub has been a key advisor at TIDES for over 15 years, shaping industry advancements and fostering collaboration. His leadership at CordenPharma has strengthened its position as a global leader in peptide and oligonucleotide development. Through his expertise and strategic vision, Dr. Ayoub continues to drive innovation, enhancing drug development and manufacturing worldwide.

Agenda Sessions

  • Tag-Assisted Peptide Synthesis (TAPS) – Development of an Efficient, Sustainable and Cost-Effective Continuous Liquid-Phase Process

    12:20pm